Evidence map›Paper›PMID 35864746›Full record

SynthesisAmerican journal of men's health

The Efficacy and Safety of HoLEP for Benign Prostatic Hyperplasia With Large Volume: A Systematic Review and Meta-Analysis.

Fengze Sun, Huibao Yao, Xingjun Bao, Xiaofeng Wang, Di Wang, Dongxu Zhang, Zhongbao Zhou, Jitao Wu

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in American journal of men's health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Refractory metabolic acidosis and acute abdominal compartment syndrome following Holmium Laser Enucleation of Prostate (HoLEP).Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Fengze SunDepartment of Urology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, China.ORCID 0000-0002-3950-0948
Huibao YaoDepartment of Urology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, China.ORCID 0000-0002-5484-6904
Xingjun BaoThe second clinical medical college, Binzhou Medical University, Yantai, Shandong, China.
Xiaofeng WangDepartment of Urology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, China.
Di WangDepartment of Urology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, China.
Dongxu ZhangDepartment of Urology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, China.
Zhongbao ZhouDepartment of Urology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Jitao WuDepartment of Urology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, China.
Qingdao University · CNBinzhou Medical University · CNCapital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This meta-analysis was to evaluate the efficacy and safety of holmium laser enucleation of prostate (HoLEP) in the treatment of benign prostatic hyperplasia (BPH) with large volume. PubMed, Embase, and Cochrane Library databases (until March 2022) were used to search related randomized controlled trials. A total of 11 studies including 1,258 patients were involved. HoLEP could significantly decrease the length of hospital stay and accelerate recovery. In subanalysis, HoLEP had better perioperative outcomes than bipolar transurethral resection of the prostate (B-TURP) and bipolar transurethral enucleation of the prostate (BPEP). The improvement in operative time and enucleation time was better in thulium laser enucleation of the prostate (ThuLEP) than HoLEP. In the follow-up period, the HoLEP decreased post-void residual urine (PVR) in short-term intervals and improved patients' maximum flow rate (Qmax) and prostate-specific antigen (PSA) in mid- and long-term intervals. In subanalysis, HoLEP presented significant improvements in Qmax, PSA, and quality of life (QoL) than B-TURP, and HoLEP could also improve Qmax than ThuLEP after 6 months of surgery. The HoLEP reduced the risk of postoperative bleeding compared with other surgeries in safety. In our study, we confirmed the advantages of HoLEP in treating BPH when the prostate size was larger than 80 mL, which indicated that HoLEP could be the best choice for treatment of large volume of prostate.

Indexed as

Lasers, Solid-StateProstatic HyperplasiaTransurethral Resection of ProstateHumansMaleProstateProstate-Specific AntigenQuality of LifeTreatment OutcomeProstate-Specific AntigenBPEPBPHB-TURPHoLEPmeta-analysisrandomized controlled trialsThuLEP

Identifiers

PMID35864746
PMCPMC9310232
OpenAlexW4286721841

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.